#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Postprandial hypoglycaemia Pericarditis Juvenile psoriatic arthritis Non-small cell lung cancer Arteriosclerosis Nasopharyngeal cancer Cutaneous T-cell lymphoma refractory Meningitis meningococcal HER2 mutant non-small cell lung cancer Oesophageal adenocarcinoma stage III Short stature homeobox gene mutation Orthostatic hypotension Piriformis syndrome Myeloproliferative neoplasm Medullary thyroid cancer More trials…

    Learn about Rare Diseases

    Hereditary angioedema with C1 esterase inhibitor deficiency X-linked lymphoproliferative syndrome Rett syndrome – Diagnostics CADASIL – Trials in Disease Sarcoidosis – Diagnostics Mucopolysaccharidosis I – Basic Information Carcinoid syndrome – Treatment MELAS syndrome – Treatment Hairy cell leukaemia – Treatment Haemophilia B without inhibitors – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gemcitabine Hydrochloride Botensilimab Platelet Concentrate Vilobelimab Ferumoxytol Vidofludimus Calcium ZALFERMIN Specific Nucleic Acid Sna-Papi Epinephrine Hydrochloride Satralizumab ATIGOTATUG Regn7508 ULTEVURSEN IG-TREGS Valoctocogene Roxaparvovec AAV9-CTNT-COBAG3 Bi 1291583 Imiglucerase Testosterone Undecanoate Insulin Human More therapies…

    Learn about Your Condition

    Plasmablastic lymphoma Retinopathy proliferative Tumour thrombosis Naevus flammeus Endocarditis Liver transplant rejection Myocarditis Impaired gastric emptying Uveal melanoma Aplastic anaemia Cardiovascular disorder Leukocyte adhesion deficiency Asthmatic crisis Burkitt's lymphoma Metastases to peritoneum More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Colchicine on Blood Vessel Function in Patients with Chronic Heart Failure and CHIP Mutations

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    Investigated Drugs:
    • Colchicine
    Germany

  • Study on the Effects of T89 and Glyceryl Trinitrate for Patients with Stable Angina

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Angina pectoris
    Investigated Drugs:
    • Glyceryl Trinitrate
    • T89
    Bulgaria Poland Romania Slovakia

  • Study of ixazomib, iberdomide and dexamethasone combination in elderly patients with first relapse of multiple myeloma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Ixazomib Citrate
    • Dexamethasone
    • Iberdomide
    France

  • Study of Intranasal Oxytocin Treatment for Patients with Benzodiazepine Withdrawal Symptoms: A Comparison with Placebo during Diazepam Dose Reduction

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Drug use disorder
    Investigated Drugs:
    • Oxytocin
    • Sodium Chloride
    Norway

  • Study on the Safety and Effectiveness of Oxitriptan and Tamsulosin Hydrochloride for Patients with Benign Prostatic Hyperplasia

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Benign prostatic hyperplasia
    Investigated Drugs:
    • Oxitriptan
    • Tamsulosin Hydrochloride
    Portugal

  • Study on the Effects of Semaglutide and Dulaglutide in Adults with Multiple Sclerosis Aged 18-60 with High Disease Activity

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Dulaglutide
    • Semaglutide
    Slovakia
Previous Page
1 … 860 861 862 863 864 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!